These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38751034)

  • 1. Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies.
    Farooqi HA; Nabi R; Hayder Z; Zahid T
    Asia Pac J Clin Oncol; 2024 Aug; 20(4):555-556. PubMed ID: 38751034
    [No Abstract]   [Full Text] [Related]  

  • 2. Methodology in plasma proteomic pattern experiments.
    Van Gorp T; Vergote IB; Pochet NL; Amant F
    Int J Gynecol Cancer; 2006; 16(5):1951-2; author reply 1953. PubMed ID: 17009999
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.
    Mikdadi D; O'Connell KA; Meacham PJ; Dugan MA; Ojiere MO; Carlson TB; Klenk JA
    Cancer Biomark; 2022; 33(2):173-184. PubMed ID: 35213360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.
    Kulasingam V; Pavlou MP; Diamandis EP
    Nat Rev Cancer; 2010 May; 10(5):371-8. PubMed ID: 20383179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence in Ovarian Cancer Diagnosis.
    Akazawa M; Hashimoto K
    Anticancer Res; 2020 Aug; 40(8):4795-4800. PubMed ID: 32727807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery in ovarian cancer.
    Tung CS; Wong KK; Mok SC
    Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).
    Wang Y; Lin W; Zhuang X; Wang X; He Y; Li L; Lyu G
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
    Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
    Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    Oaknin A; Guarch R; Barretina P; Hardisson D; González-Martín A; Matías-Guiu X; Pérez-Fidalgo A; Vieites B; Romero I; Palacios J
    Clin Transl Oncol; 2018 Mar; 20(3):274-285. PubMed ID: 28815456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
    Bonifácio VDB
    Adv Exp Med Biol; 2020; 1219():355-363. PubMed ID: 32130708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential of proteomics in the diagnosis of ovarian cancer.
    Ardekani AM; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2002 Jul; 2(4):312-20. PubMed ID: 12138495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunologic diagnosis of cancer. Ovarian cancer.
    Stenman UH; Seppälä M
    Tumour Biol; 1987; 8(2-3):109-12. PubMed ID: 2834812
    [No Abstract]   [Full Text] [Related]  

  • 14. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
    Pawar S; Liew TO; Stanam A; Lahiri C
    Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genomic biomarkers of risk in ovarian cancer.
    Pinheiro SP; Cramer DW
    Dis Markers; 2007; 23(5-6):355-66. PubMed ID: 18057519
    [No Abstract]   [Full Text] [Related]  

  • 16. Explainable discovery of disease biomarkers: The case of ovarian cancer to illustrate the best practice in machine learning and Shapley analysis.
    Huang W; Suominen H; Liu T; Rice G; Salomon C; Barnard AS
    J Biomed Inform; 2023 May; 141():104365. PubMed ID: 37062419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer.
    Salima S; Rachmawati A; Harsono AB; Erfiandi F; Fauzi H; Prasekti H; Nurita R
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2643-2647. PubMed ID: 36037117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HE4 as a biomarker for ovarian and endometrial cancer management.
    Li J; Dowdy S; Tipton T; Podratz K; Lu WG; Xie X; Jiang SW
    Expert Rev Mol Diagn; 2009 Sep; 9(6):555-66. PubMed ID: 19732003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning analysis of proteomics data for early diagnosis.
    Devetyarov D
    Stud Health Technol Inform; 2009; 150():772. PubMed ID: 19745415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constructing support vector machine ensembles for cancer classification based on proteomic profiling.
    Mao Y; Zhou XB; Pi DY; Sun YX
    Genomics Proteomics Bioinformatics; 2005 Nov; 3(4):238-41. PubMed ID: 16689692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.